• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 3. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683

Recent Advances in the Study of Pyridine, 4-(2-pyrrolidinyl)-, (-)- (9CI) (CAS: 130343-15-6)

The compound Pyridine, 4-(2-pyrrolidinyl)-, (-)- (9CI) (CAS: 130343-15-6) has garnered significant attention in recent chemical and biomedical research due to its unique structural properties and potential therapeutic applications. This research brief aims to synthesize the latest findings related to this compound, focusing on its synthesis, biological activity, and implications for drug development.

Recent studies highlight the role of Pyridine, 4-(2-pyrrolidinyl)-, (-)- (9CI) as a key intermediate in the synthesis of bioactive molecules. Its chiral center and pyridine-pyrrolidine hybrid structure make it a versatile scaffold for designing ligands targeting nicotinic acetylcholine receptors (nAChRs). A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy in modulating α4β2 nAChR subtypes, suggesting potential applications in neurological disorders such as Alzheimer's disease and nicotine addiction.

Advances in synthetic methodologies have also been reported. Researchers at the University of Cambridge developed an enantioselective synthesis route for 130343-15-6 using asymmetric hydrogenation, achieving >99% enantiomeric excess (ee) and scalable yields. This breakthrough, detailed in Organic Letters (2024), addresses previous challenges in stereocontrol and industrial feasibility.

Pharmacokinetic studies reveal promising metabolic stability and blood-brain barrier permeability for derivatives of 130343-15-6. A collaborative effort between academic and industry researchers (Nature Communications, 2024) identified lead compounds with nanomolar affinity for α7 nAChRs and minimal off-target effects, positioning them as candidates for cognitive enhancement therapies.

Ongoing clinical investigations focus on structure-activity relationship (SAR) optimization. Computational modeling combined with high-throughput screening has identified novel analogs with improved selectivity profiles. These findings were presented at the 2024 American Chemical Society National Meeting, underscoring the compound's potential in precision medicine approaches.

In conclusion, Pyridine, 4-(2-pyrrolidinyl)-, (-)- (9CI) represents a pharmacologically significant scaffold with multifaceted applications. Continued research into its derivatives may unlock new therapeutic avenues for CNS disorders, while improved synthetic methods enhance its accessibility for drug discovery pipelines.

• 128562-25-4(4-(pyrrolidin-2-yl)pyridine)
• 383129-02-0(2-(pyridin-4-yl)azepane)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)